Hypoxia affects mesoderm and enhances hemangioblast specification during early development

Development

Volumn 131, Issue 18, 2004, Pages 4623-4634

  Ramírez Bergeron, Diana L ^a   Runge, Anja ^a   Cowden Dahl, Karen D ^a   Fehling, Hans Joerg ^b   Keller, Gordon ^c   Simon, M Celeste ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

ARNT; Hemangioblast; HIF; Hypoxia; Mesoderm

Indexed keywords

OXYGEN; TRANSCRIPTION FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL SPECIFICITY; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; HEMATOPOIETIC CELL; HYPOXIA; KINETICS; MESODERM; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ANIMALS; ANOXIA; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BONE MORPHOGENETIC PROTEINS; CELL COUNT; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; COCULTURE TECHNIQUES; DNA-BINDING PROTEINS; FETAL PROTEINS; GENE DELETION; GROWTH SUBSTANCES; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KINETICS; MESODERM; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; PHENOTYPE; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; STEM CELLS; T-BOX DOMAIN PROTEINS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

ANIMALIA; MAMMALIA;

EID: 6944233515     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.01310     Document Type: Article

References (64)

1. Adelman, D. M., Maltepe, E. and Simon, M. C. (1999). Multilineage embryonic hematopoiesis requires hypoxic ARNT activity. Genes Dev. 13, 2478-2483.
2. Adelman, D. M., Gertsenstein, M., Nagy, A., Simon, M. C. and Maltepe, E. (2000). Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev. 14, 3191-3203.
3. Bianchi, L., Tacchini, L. and Cairo, G. (1999). HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. Nucl. Acids Res. 27, 4223-4227.
4. Carmeliet, P., Ferreira, V., Breir, G., Pollefeyt, S., Kieckens, L., Gertenstein, M., Fahrig, M., Vandenhoeck, A., Harpal., K., Eberhard, C. et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 435-439.
5. Choi, K. (1998). Hemangioblast development and regulation. Biochem. Cell Biol. 76, 947-956.
6. Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C. and Keller, G. (1998). A common precursor for hematopoietic and endothelial cells. Development 125, 725-732.
7. Chung, Y. S., Zhang, W. J., Arentson, E., Kingsley, P. D., Palis, J. and Choi, K. (2002). Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression. Development 129, 5511-5520.
8. Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G. W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J. and Maxwell, P. H. (2000). Hypoxia inducible factor-alpha binding and ubiquitylation by the Von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733-25741.
9. Corpechot, C., Barbu, V., Wendum, D., Kinnman, N., Rey, C., Poupon, R., Housset, C. and Rosmorduc, O. (2002). Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 35, 1010-1021.
10. Czyz, J. and Wobus, A. (2001). Embryonic stem cell differentiation: the role of extracellular factors. Differentiation 68, 167-174.
11. de Bruijn, M. F., Ma, X., Robin, C., Ottersbach, K., Sanchez, M. J. and Dzierzak, E. (2002). Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta. Immunity 16, 673-683.
12. Dumont, D. J., Fong, G. H., Puri, M. C., Gradwohl, G., Alitalo, K. and Breitman, M. L. (1995). Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 203, 80-92.
13. Ema, M., Faloon, P., Zhang, W. J., Hirashima, M., Reid, T., Stanford, W.L., Orkin, S., Choi, K. and Rossant, J. (2003). Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev. 17, 380-393.
14. Faloon, P., Arentson, E., Kazarov, A., Deng, C. X., Porcher, C., Orkin, S. and Choi, K. (2000). Basic fibroblast growth factor positively regulates hematopoietic development. Development 127, 1931-1941.
15. Fehling, H. J., Lacaud, G., Kubo, A., Kennedy, M., Robertson, S., Keller, G. and Kouskoff, V. (2003). Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 130, 4217-4227.
16. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D. and Semenza, G. L. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604-4613.
17. Gerber, H. P., Condorelli, F., Park, J. and Ferrara, N. (1997). Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem. 272, 23659-23667.
18. Gleadle, J. M., Ebert, B. L., Firth, J. D. and Ratcliffe, P. J. (1995). Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am. J. Physiol. 268, C1362-C1368.
19. Gu, Y. Z., Hogenesch, J. B. and Bradfield, C. A. (2000). The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40, 519-561.
20. Haar, J. L. and Ackerman, G. A. (1971). Ultrastructural changes in mouse yolk sac associated with the initiation of vitelline circulation. Anat. Rec. 170, 437-455.
21. Hogan, B. L. (1996). Bone morphogenetic proteins in development. Curr. Opin. Genet. Dev. 6, 432-438.
22. Hu, C. J., Wang, L. Y., Chodosh, L. A., Keith, B. and Simon, M. C. (2003). Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell. Biol. 23, 9361-9374.
23. Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y. et al. (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12 149-162.
24. Jones, C. M., Dale, L., Hogan, B. L., Wright, C. V. and Smith, J. C. (1996). Bone morphogenetic protein-4 (BMP-4) acts during gastrula stages to cause ventralization of Xenopus embryos. Development 122, 1545-1554.
25. Keith, B., Adelman, D. M. and Simon, M. C. (2001). Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt. Proc. Natl. Acad. Sci. USA 98, 6692-6697.
26. Keller, G. M. (1995). In vitro differentiation of embryonic stem cells. Curr. Opin. Cell Biol. 7, 862-869.
27. Keller, G., Kennedy, M., Papayannopoulou, T. and Wiles, M. V. (1993). Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol. 13, 473-486.
28. Kennedy, M., Firpo, M., Choi, K., Wall, C., Robertson, S., Kabrun, N. and Keller, G. (1997). A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 386, 488-493.
29. Kotch, L. E., Iyer, N. V., Laughner, E. and Semenza, G. L. (1999). Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev. Biol. 209, 254-267.
30. Kourembanas, S., Hannan, R. L. and Faller, D. V. (1990). Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J. Clin. Invest. 86, 670-674.
31. Lacaud, G., Gore, L., Kennedy, M., Kouskoff, V., Kingsley, P., Hogan, C., Carlsson, L., Speck, N., Palis, J. and Keller, G. (2002). Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood 100, 458-466.
32. Liu, Y., Cox, S. R., Morita, T. and Kourembanas, S. (1995). Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res. 77, 638-643.
33. Lok, C. N. and Ponka, P. (1999). Identification of a hypoxia response element in the transferrin receptor gene. J. Biol. Chem. 274, 24147-24152.
34. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A. and Simon, M. C. (1997). Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386, 403-407.
35. Maxwell, P. H., Pugh, C. W. and Ratcliffe, P. J. (1993). Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc. Natl. Acad. Sci. USA 90, 2423-2427.
36. Maxwell, P. H., Wiesener, M. S., Chang, G. W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R. and Ratcliffe, P. J. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275.
37. Medvinsky, A. and Dzierzak, E. (1996). Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86, 897-906.
38. Mitchell, J. A. and Yochim, J. M. (1968). Measurement of intrauterine oxygen tension in the rat and its regulation by ovarian steroid hormones. Endocrinology 83, 691-700.
39. Muller, A. M., Medvinsky, A., Strouboulis, J., Grosveld, F. and Dzierzak, E. (1994). Development of hematopoietic stem cell activity in the mouse embryo. Immunity 1, 291-301.
40. Muller, P. Y., Janovjak, H., Miserez, A. R. and Dobbie, Z. (2002). Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32, 1372-1379.
41. North, T. E., de Bruijn, M. F., Stacy, T., Talebian, L., Lind, E., Robin, C., Binder, M., Dzierzak, E. and Speck, N. A. (2002 . Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity 16, 661-672.
42. Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T. Y., Huang, L. E., Pavletich, N., Chau, V. and Kaelin, W. G. (2000). Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2 423-427.
43. Pardanaud, L. and Dieterlen-Lievre, F. (1999). Manipulation of the angiopoietic/hemangiopoietic commitment in the avian embryo. Development 126, 617-627.
44. Ramirez-Bergeron, D. L. and Simon, M. C. (2001). Hypoxia-inducible factor and the development of stem cells of the cardiovascular system. Stem Cells 19, 279-286.
45. Robb, L., Lyons, I., Li, R., Hartley, L., Kontgen, F., Harvey, R. P., Metcalf, D. and Begley, C. G. (1995). Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. USA 92, 7075-7079.
46. Robertson, S. M., Kennedy, M., Shannon, J. M. and Keller, G. (2000). A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development 127, 2447-2459.
47. Rodesch, F., Simon, P., Donner, C. and Jauniaux, E. (1992). Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet. Gynecol. 80, 283-285.
48. Rolfs, A., Kvietikova, I., Gassmann, M. and Wenger, R. H. (1997). Oxygen-regulated transferrin expression is mediated by hypoxia- inducible factor-1. J. Biol. Chem. 272, 20055-20062.
49. Ryan, H. E., Lo, J. and Johnson, R. S. (1998). HIF-1a is required for solid tumor formation and embryonic vascularization. EMBO J. 17, 3005-3015.
50. Sabin, F. (1920). Studies on the origin of blood vessels and of red corpuscles as seen in the living blastoderm of the chick during the second day of incubation. Contrib. Embryol. 9 213-262.
51. Schuh, A. C., Faloon, P., Hu, Q. L., Bhimani, M. and Choi, K. (1999). In vitro hematopoietic and endothelial potential of flk-1(-/-) embryonic stem cells and embryos. Proc. Natl. Acad. Sci. USA 96, 2159-2164.
52. Seagroves, T. N., Hadsell, D., McManaman, J., Palmer, C., Liao, D., McNulty, W., Welm, B., Wagner, K. U., Neville, M. and Johnson, R. S. (2003). HIF1alpha is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. Development 130, 1713-1724.
53. Semenza, G. L. (1998). Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr. Opin. Genet. Dev. 8 588-594.
54. Semenza, G. L. (1999). Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15, 551-578.
55. Semenza, G. L., Nejfelt, M. K., Chi, S. M. and Antonarakis, S. E. (1991). Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. USA 88, 5680-5684.
56. Semenza, G. L., Roth, P. H., Fang, H.-M. and Wang, G. L. (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757-23769.
57. Shivdasani, R. A., Mayer, E. L. and Orkin, S. H. (1995). Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373, 432-434.
58. Tacchini, L., Bianchi, L., Bernelli-Zazzera, A. and Cairo, G. (1999). Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 274, 24142-24146.
59. Visvader, J. E., Fujiwara, Y. and Orkin, S. H. (1998). Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev. 12, 473-479.
60. 2 tension. Proc. Natl. Acad Sci. USA 92, 5510-5514.
61. Wang, Z., Cohen, K., Shao, Y., Mole, P., Dombkowski, D. and Scadden, D. T. (2004). Ephrin receptor, EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts, blood, cardiomyocytes, and blood vessels. Blood 103, 100-109.
62. Winnier, G., Blessing, M., Labosky, P. A. and Hogan, B. L. (1995). Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 9, 2105-2116.
63. Wood, S. M., Gleadle, J. M., Pugh, C. W., Hankinson, O. and Ratcliffe, P. J. (1996). The role of aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxia induction of gene expression. J. Biol. Chem. 271, 15117-15123.
64. Yamashita, J., Itoh, H., Hirashima, M., Ogawa, M., Nishikawa, S., Yurugi, T., Naito, M. and Nakao, K. (2000). Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408, 92-96.